| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 140, Issue 8 2686-2694, Copyright © 1988 by American Association of Immunologists
ARTICLES |
AK Lichtenstein, T Ganz, TM Nguyen, ME Selsted and RI Lehrer
Department of Medicine, VA Wadsworth-UCLA Medical Center 90073.
In a previous study, potent tumor cytolysis mediated by human neutrophil peptide defensins occurred slowly over 3 to 15 h. Because these kinetics suggested a requirement for target cell metabolic processes before tumor killing could be realized, the mechanism of lysis by these purified peptides was further investigated. 125I-labeled defensin bound extensively to peptide-sensitive K562 targets with biphasic kinetics. Binding was inhibited in parallel with cytotoxicity when both assays were performed at low temperature or in the presence of FCS. The albumin content of serum could account for the inhibitory effects of FCS. Cytotoxicity was also antagonized by agents that interfered with target cell energy metabolism (azide and 2- deoxyglucose), the cytoskeletal apparatus (cytochalasin B and dihydrocytochalasin B), lysosomal function (NH4Cl and chloraquin), or calmodulin-mediated activities (trifluoperazine). FCS also completely removed membrane-bound defensin when it was added after 5 min of binding at 37 degrees C. However, significantly less defensin was removed when FCS was added at later time points after binding was initiated. Cytochalasin B and azide/2-deoxyglucose did not prevent binding of defensin to targets but it significantly inhibited the development of FCS resistance in membrane-bound peptide. However, these two classes of inhibitors acted during distinct time windows: cytochalasin-sensitive events were complete by 1 h, whereas azide/2- deoxyglucose continued to be inhibitory when added as late as 2 h after defensins. These latter data indicated that critical energy-dependent events continue after the cytochalasin-sensitive phase has been completed. The results suggest that defensin-mediated cytotoxicity requires initial binding of defensin molecules to targets and subsequent cytoskeletal- and energy-dependent translocation or internalization. Although the defensins are low m.w. peptides, the initial processes required for their cytotoxic activity resemble those of more complex bacterial, plant and mammalian cytotoxins.
This article has been cited by other articles:
|
|
 |
|
  S. Kota, A. Sabbah, T. H. Chang, R. Harnack, Y. Xiang, X. Meng, and S. Bose Role of Human {beta}-Defensin-2 during Tumor Necrosis Factor-{alpha}/NF-{kappa}B-mediated Innate Antiviral Response against Human Respiratory Syncytial Virus J. Biol. Chem., August 15, 2008; 283(33): 22417 - 22429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Xu, Y.-s. Wang, W.-b. Pan, B. Xiao, Y.-j. Wen, X.-c. Chen, L.-j. Chen, H.-x. Deng, J. You, B. Kan, et al. Human {alpha}-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice Mol. Cancer Ther., June 1, 2008; 7(6): 1588 - 1597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tecle, M. R. White, D. Gantz, E. C. Crouch, and K. L. Hartshorn Human Neutrophil Defensins Increase Neutrophil Uptake of Influenza A Virus and Bacteria and Modify Virus-Induced Respiratory Burst Responses J. Immunol., June 15, 2007; 178(12): 8046 - 8052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Weeks, H. Tanabe, J. E. Cummings, S. P. Crampton, T. Sheynis, R. Jelinek, T. K. Vanderlick, M. J. Cocco, and A. J. Ouellette Matrix Metalloproteinase-7 Activation of Mouse Paneth Cell Pro-{alpha}-defensins: SER43{downarrow}ILE44 PROTEOLYSIS ENABLES MEMBRANE-DISRUPTIVE ACTIVITY J. Biol. Chem., September 29, 2006; 281(39): 28932 - 28942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Hartshorn, M. R. White, T. Tecle, U. Holmskov, and E. C. Crouch Innate Defense against Influenza A Virus: Activity of Human Neutrophil Defensins and Interactions of Defensins with Surfactant Protein D. J. Immunol., June 1, 2006; 176(11): 6962 - 6972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Viejo-Diaz, M. T. Andres, and J. F. Fierro Modulation of In Vitro Fungicidal Activity of Human Lactoferrin against Candida albicans by Extracellular Cation Concentration and Target Cell Metabolic Activity Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1242 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Brissette and S. A. Lukehart Treponema denticola Is Resistant to Human {beta}-Defensins Infect. Immun., July 1, 2002; 70(7): 3982 - 3984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Muller, J. Markovic-Lipkovski, T. Klatt, J. Gamper, G. Schwarz, H. Beck, M. Deeg, H. Kalbacher, S. Widmann, J. T. Wessels, et al. Human {alpha}-Defensins HNPs-1, -2, and -3 in Renal Cell Carcinoma : Influences on Tumor Cell Proliferation Am. J. Pathol., April 1, 2002; 160(4): 1311 - 1324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Risso, E. Braidot, M. C. Sordano, A. Vianello, F. Macri, B. Skerlavaj, M. Zanetti, R. Gennaro, and P. Bernardi BMAP-28, an Antibiotic Peptide of Innate Immunity, Induces Cell Death through Opening of the Mitochondrial Permeability Transition Pore Mol. Cell. Biol., March 15, 2002; 22(6): 1926 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Helmerhorst, R. F. Troxler, and F. G. Oppenheim The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species PNAS, November 15, 2001; (2001) 141366998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Mystkowska, A. Niemierko, A. Komar, and W. Sawicki Embryotoxicity of magainin-2-amide and its enhancement by cyclodextrin, albumin, hydrogen peroxide and acidification Hum. Reprod., July 1, 2001; 16(7): 1457 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vlahou, P. F. Schellhammer, S. Mendrinos, K. Patel, F. I. Kondylis, L. Gong, S. Nasim, and G. L. Wright Jr. Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in Urine Am. J. Pathol., April 1, 2001; 158(4): 1491 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lupetti, A. Paulusma-Annema, M. M. Welling, S. Senesi, J. T. van Dissel, and P. H. Nibbering Candidacidal Activities of Human Lactoferrin Peptides Derived from the N Terminus Antimicrob. Agents Chemother., December 1, 2000; 44(12): 3257 - 3263. [Abstract] [Full Text]
|
|
|
|
|
|
M. Edgerton, S. E. Koshlukova, M. W. B. Araujo, R. C. Patel, J. Dong, and J. A. Bruenn Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways Antimicrob. Agents Chemother., December 1, 2000; 44(12): 3310 - 3316. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Risso Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity J. Leukoc. Biol., December 1, 2000; 68(6): 785 - 792. [Abstract] [Full Text]
|
|
|
|
|
|
D. Yang, Q. Chen, O. Chertov, and J. J. Oppenheim Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells J. Leukoc. Biol., July 1, 2000; 68(1): 9 - 14. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Tani, W. J. Murphy, O. Chertov, R. Salcedo, C. Y. Koh, I. Utsunomiya, S. Funakoshi, O. Asai, S. H. Herrmann, J. M. Wang, et al. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens Int. Immunol., May 1, 2000; 12(5): 691 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gyurko, U. Lendenmann, R. F. Troxler, and F. G. Oppenheim Candida albicans Mutants Deficient in Respiration Are Resistant to the Small Cationic Salivary Antimicrobial Peptide Histatin 5 Antimicrob. Agents Chemother., February 1, 2000; 44(2): 348 - 354. [Abstract] [Full Text]
|
|
|
|
|
|
S. Nagpal, V. Gupta, K. J. Kaur, and D. M. Salunke Structure-Function Analysis of Tritrypticin, an Antibacterial Peptide of Innate Immune Origin J. Biol. Chem., August 13, 1999; 274(33): 23296 - 23304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Kaplan, R. P. Heine, and R. L. Simmons Defensins Impair Phagocytic Killing by Neutrophils in Biomaterial-Related Infection Infect. Immun., April 1, 1999; 67(4): 1640 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Helmerhorst, P. Breeuwer, W. van `t Hof, E. Walgreen-Weterings, L. C. J. M. Oomen, E. C. I. Veerman, A. V. N. Amerongen, and T. Abee The Cellular Target of Histatin 5 on Candida albicans Is the Energized Mitochondrion J. Biol. Chem., March 12, 1999; 274(11): 7286 - 7291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A.-R. Higazi, T. Ganz, K. Kariko, and D. B. Cines Defensin Modulates Tissue-type Plasminogen Activator and Plasminogen Binding to Fibrin and Endothelial Cells J. Biol. Chem., July 26, 1996; 271(30): 17650 - 17655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Helmerhorst, R. F. Troxler, and F. G. Oppenheim The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species PNAS, December 4, 2001; 98(25): 14637 - 14642. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
